Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Chong-chong Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7542-0796; OpenAlex author ID A5102762276. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. [Progress in the diagnosis and treatment of pancreatic cancer with acute pancreatitis as the initial symptom]. First author DOI 10.3760/cma.j.cn112139-20240418-00192↗
  2. Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine. Co-author DOI 10.1007/s13277-015-4641-2↗
  3. MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer. Co-author DOI 10.1007/s12032-014-0418-5↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. R Jiang · 1 shared paper, 2024 · strength 0.24
  2. Fei Li · 1 shared paper, 2024 · strength 0.24
  3. Fei Li · 1 shared paper, 2016 · strength 0.06
  4. Hua Jiang · 1 shared paper, 2016 · strength 0.06
  5. Fei Li · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.